117 related articles for article (PubMed ID: 37528722)
21. Investigation of the expression levels of CDH1, FHIT, PTEN, and TTPAL genes in colorectal tumors.
Arıkan Söylemez ESS; Söylemez Z; Çilekar M; Arıkan Y; Tokyol Ç; Kenger İH; Solak M
Turk J Med Sci; 2022 Feb; 52(1):124-130. PubMed ID: 36161592
[TBL] [Abstract][Full Text] [Related]
22. Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric Glioma.
Karlowee V; Amatya VJ; Hirano H; Takayasu T; Nosaka R; Kolakshyapati M; Yoshihiro M; Takeshima Y; Sugiyama K; Arita K; Kurisu K; Yamasaki F
Pathobiology; 2017; 84(2):99-107. PubMed ID: 27553586
[TBL] [Abstract][Full Text] [Related]
23. Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab.
Lv S; Teugels E; Sadones J; De Brakeleer S; Duerinck J; Du Four S; Michotte A; De Grève J; Neyns B
Int J Oncol; 2012 Sep; 41(3):1029-35. PubMed ID: 22752145
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
Hersh DS; Peng S; Dancy JG; Galisteo R; Eschbacher JM; Castellani RJ; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
J Neurooncol; 2018 Jun; 138(2):241-250. PubMed ID: 29453678
[TBL] [Abstract][Full Text] [Related]
25. Expression of neu/c-erbB-2 in human brain tumors.
Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
[TBL] [Abstract][Full Text] [Related]
26. Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.
Gessler F; Zappi J; Konczalla J; Bernstock JD; Forster MT; Wagner M; Mittelbronn M; Seifert V; Senft C
World Neurosurg; 2017 Jun; 102():49-55. PubMed ID: 28263929
[TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
van de Nes JA; Griewank KG; Schmid KW; Grabellus F
Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
[TBL] [Abstract][Full Text] [Related]
28. IDH1 R132H Mutation Is Accompanied with Malignant Progression of Paired Primary-Recurrent Astrocytic Tumours.
Mu L; Xu W; Li Q; Ge H; Bao H; Xia S; Ji J; Jiang J; Song Y; Gao Q
J Cancer; 2017; 8(14):2704-2712. PubMed ID: 28928859
[TBL] [Abstract][Full Text] [Related]
29. IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance.
Thota B; Shukla SK; Srividya MR; Shwetha SD; Arivazhagan A; Thennarasu K; Chickabasaviah YT; Hegde AS; Chandramouli BA; Somasundaram K; Santosh V
Am J Clin Pathol; 2012 Aug; 138(2):177-84. PubMed ID: 22904127
[TBL] [Abstract][Full Text] [Related]
30. Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas--Same Entity or First Cousins?
Alexandrescu S; Korshunov A; Lai SH; Dabiri S; Patil S; Li R; Shih CS; Bonnin JM; Baker JA; Du E; Scharnhorst DW; Samuel D; Ellison DW; Perry A
Brain Pathol; 2016 Mar; 26(2):215-23. PubMed ID: 26238627
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.
Bourgonje AM; Verrijp K; Schepens JT; Navis AC; Piepers JA; Palmen CB; van den Eijnden M; Hooft van Huijsduijnen R; Wesseling P; Leenders WP; Hendriks WJ
Acta Neuropathol Commun; 2016 Sep; 4(1):96. PubMed ID: 27586084
[TBL] [Abstract][Full Text] [Related]
32. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
33. Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients.
Zhao HF; Zhou XM; Wang J; Chen FF; Wu CP; Diao PY; Cai LR; Chen L; Xu YW; Liu J; Li ZY; Liu WL; Chen ZP; Huang GD; Li WP
J Transl Med; 2021 Aug; 19(1):372. PubMed ID: 34461927
[TBL] [Abstract][Full Text] [Related]
34. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
35. Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status.
Cemeus C; Zhao TT; Barrett GM; Lorimer IA; Dimitroulakos J
J Neurooncol; 2008 Oct; 90(1):9-17. PubMed ID: 18566746
[TBL] [Abstract][Full Text] [Related]
36. Low expression of isocitrate dehydrogenase 1 (IDH1) R132H is associated with advanced pathological features in laryngeal squamous cell carcinoma.
Shayanfar N; Zare-Mirzaie A; Mohammadpour M; Jafari E; Mehrtash A; Emtiazi N; Tajik F
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4253-4267. PubMed ID: 36063222
[TBL] [Abstract][Full Text] [Related]
37. PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma.
Rodriguez EF; Scheithauer BW; Giannini C; Rynearson A; Cen L; Hoesley B; Gilmer-Flynn H; Sarkaria JN; Jenkins S; Long J; Rodriguez FJ
Acta Neuropathol; 2011 Mar; 121(3):407-20. PubMed ID: 21113787
[TBL] [Abstract][Full Text] [Related]
38. Copy Number Profiling of Brazilian Astrocytomas.
Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM
G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation-mediated down-regulation of RUNX3 gene in human brain tumors.
Avci CB; Dodurga Y; Susluer SY; Sıgva ZO; Yucebas M; Caglar HO; Akalin T; Dalbasti T; Oktar N; Gunduz C
Ir J Med Sci; 2014 Jun; 183(2):259-64. PubMed ID: 23934435
[TBL] [Abstract][Full Text] [Related]
40. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas.
Tsai WC; Chen Y; Huang LC; Lee HS; Ma HI; Huang SM; Sytwu HK; Hueng DY
J Neurooncol; 2013 Sep; 114(3):281-90. PubMed ID: 23817808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]